Manas Mishra
Manas Mishra
Correspondent @Reuters. Follow for healthcare/business related news and my obscure interests on your feed.Source
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
2 reviews

RECENT ARTICLES

Sort by:
No Rating
Johnson & Johnson COVID-19 vaccine backed by advisory panel, U.S. authorization to follow

Johnson & Johnson COVID-19 vaccine backed by advisory panel, U.S. authorization to follow

By , (Reuters) - A panel of expert advisers to the U.S. Food and Drug Administration on Friday voted to recommend authorization of Johnson & Johnson’s one-dose COVID-19 vaccine for emergency use, bringing it an important step closer to a U.S. rollout.The FDA is likely to authorize the vaccine for emergency use within a day or so, making it the third available in the United States, and the only one that requires a single shot.The panel consisting of doctors, infectious disease experts and medical researchers voted unanimously that the benefits of the vaccine outweigh its risks in people age...

Feb 26
Worthy
Share
Save
Give Tip
Review
No Rating
Two masks, snug fit reduces COVID-19 spread, U.S. study shows

Two masks, snug fit reduces COVID-19 spread, U.S. study shows

By (Reuters) - Making sure a mask fits snugly on the face and use of two masks is likely to significantly reduce a person’s exposure to the coronavirus, laboratory experiments described by U.S. health officials on Wednesday showed.Slideshow The U.S. Centers of Disease Control and Prevention (CDC) in January conducted experiments to see how well wearing a cloth mask over a three-ply medical procedure mask, and knotting the ear loops of a surgical mask and then tucking the excess material close to the face, protects against COVID-19.They found that both these methods helped reduce the...

Feb 10
Worthy
Share
Save
Give Tip
Review
No Rating
Novavax on track to begin U.S. trial of COVID-19 vaccine this month

Novavax on track to begin U.S. trial of COVID-19 vaccine this month

By , (Reuters) - Novavax Inc said on Monday it was on track to begin a delayed U.S.-based, late-stage study of its experimental coronavirus vaccine later this month.The company also said the vaccine, NVX-CoV2373, had been given “fast-track” status from the U.S. Food and Drug Administration and that it expected data from the trial could support U.S. authorization and approval.Novavax, which is testing the vaccine in a late-stage study in the UK, last month postponed the start of its U.S. trial by roughly a month, due to delays in scaling up the manufacturing process.A handful of companies...

+1
Nov 9
Worthy
Share
Save
Give Tip
Review
No Rating
Moderna shares jump on $1.5 billion U.S. contract for COVID-19 vaccine

Moderna shares jump on $1.5 billion U.S. contract for COVID-19 vaccine

United States (Reuters) - Shares of Moderna Inc () rose more than 5% on Wednesday after analysts said a $1.5 billion coronavirus vaccine supply agreement with the U.S. government could lead to similar deals with other countries. The United States and Moderna announced the agreement for 100 million doses of its potential COVID-19 vaccine late on Tuesday. The company’s vaccine candidate, mRNA-1273, is one of the few that have already advanced to the final stage of testing. The deal confirms Moderna’s experimental vaccine is one of the leading contenders, said BMO analyst George Farmer, who...

August 12, 2020
Worthy
Share
Save
Give Tip
Review
No Rating
Pfizer says it will charge other developed countries on par with U.S. for vaccine deals

Pfizer says it will charge other developed countries on par with U.S. for vaccine deals

Pfizer Inc on Tuesday said other developed countries would not get a lower price for its coronavirus vaccine than what it will charge the United States under a contract announced last week, and suggested that people may need multiple vaccinations in order to remain protected. The U.S. government agreed to pay nearly $2 billion to buy enough of a COVID-19 vaccine being developed by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course. "All the countries that are developed right now will not receive a lower price for the same...

July 28, 2020
Worthy
Share
Save
Give Tip
Review
  • Total 5 items
  • 1
OUTLETS
reuters.com

reuters.com

CRITIC
img-trusted
100%
PUBLIC
img-trusted
75%
yahoo.com

yahoo.com

CRITIC
img-trusted
94%
PUBLIC
img-trusted
78%